Hutchison China MediTech Limited (LON:HCM)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.00 and traded as high as $369.50. Hutchison China MediTech shares last traded at $355.00, with a volume of 23,131 shares changing hands.
Separately, HSBC initiated coverage on HUTCHISON CHINA/S in a report on Wednesday, March 27th. They issued a “buy” rating for the company.
The company has a debt-to-equity ratio of 8.26, a current ratio of 3.45 and a quick ratio of 3.10. The stock has a market capitalization of $2.37 billion and a price-to-earnings ratio of -28.40. The company’s fifty day moving average price is GBX 874.22.
Hutchison China MediTech Limited, a commercial-stage biopharmaceutical company, engages in discovery, development, and commercialization of targeted therapeutics and immunotherapies for oncology and immunological diseases in the People's Republic of China and Hong Kong. The company operates through Innovation Platform and Commercial Platform segments.
Featured Story: Cash Flow
Receive News & Ratings for Hutchison China MediTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hutchison China MediTech and related companies with MarketBeat.com's FREE daily email newsletter.